Free Trial

Compare Stocks

Compare stocks with our powerful stock comparison tool. Analyze fundamentals, price performance, and key financial indicators to make informed investment decisions. Our tool lets you compare up to ten stocks side by side based on Performance Charts, Price & Volume, MarketRank™, Analyst Ratings, Sales & Book Value, Profitability & Earnings, Dividends, Debt, Ownership, Headlines, and more. Simply enter up to ten stock symbols (e.g., BAC, JPM, WFC, C, GS) to get started and uncover top investment opportunities.

CompanyCurrent Price50-Day Moving Average52-Week RangeMarket CapBetaAvg. VolumeToday's Volume
Nymox Pharmaceutical Co. stock logo
NYMX
Nymox Pharmaceutical
$0.34
$0.17
$0.74
$18.10M0.6494,622 shs932,700 shs
Oxford Immunotec Global PLC stock logo
OXFD
Oxford Immunotec Global
$21.99
$21.98
$8.37
$23.11
$570.90M1.421.10 million shsN/A
Riot Platforms, Inc. stock logo
RIOT
Riot Platforms
$12.17
-0.3%
$9.31
$6.19
$15.87
$4.35B4.5728.61 million shs27.63 million shs
Meridian Bioscience, Inc. stock logo
VIVO
Meridian Bioscience
$33.97
$33.70
$20.35
$34.38
$1.50B0.23973,737 shsN/A
Vermillion, Inc. stock logo
VRML
Vermillion
$0.17
+10.8%
$3.26
$0.35
$5.78
$16.73M3.47440,144 shs296,771 shs
 The Best Nuclear Energy Stocks to Buy Cover

Nuclear energy stocks are roaring. It's the hottest energy sector of the year. Cameco Corp, Paladin Energy, and BWX Technologies were all up more than 40% in 2024. The biggest market moves could still be ahead of us, and there are seven nuclear energy stocks that could rise much higher in the next several months. To unlock these tickers, enter your email address below.

Get This Free Report

Compare Price Performance

Company1-Day Performance7-Day Performance30-Day Performance90-Day Performance1-Year Performance
Nymox Pharmaceutical Co. stock logo
NYMX
Nymox Pharmaceutical
0.00%0.00%0.00%0.00%0.00%
Oxford Immunotec Global PLC stock logo
OXFD
Oxford Immunotec Global
0.00%0.00%0.00%0.00%0.00%
Riot Platforms, Inc. stock logo
RIOT
Riot Platforms
0.00%+15.35%+35.36%+70.43%+27.16%
Meridian Bioscience, Inc. stock logo
VIVO
Meridian Bioscience
0.00%0.00%0.00%0.00%0.00%
Vermillion, Inc. stock logo
VRML
Vermillion
0.00%+7.38%+95.23%+71.46%-81.72%
CompanyOverall ScoreAnalyst's OpinionShort Interest ScoreDividend StrengthESG ScoreNews and Social Media SentimentCompany OwnershipEarnings & Valuation
Nymox Pharmaceutical Co. stock logo
NYMX
Nymox Pharmaceutical
N/AN/AN/AN/AN/AN/AN/AN/A
Oxford Immunotec Global PLC stock logo
OXFD
Oxford Immunotec Global
N/AN/AN/AN/AN/AN/AN/AN/A
Riot Platforms, Inc. stock logo
RIOT
Riot Platforms
1.6515 of 5 stars
3.52.00.00.01.50.80.0
Meridian Bioscience, Inc. stock logo
VIVO
Meridian Bioscience
N/AN/AN/AN/AN/AN/AN/AN/A
Vermillion, Inc. stock logo
VRML
Vermillion
N/AN/AN/AN/AN/AN/AN/AN/A
CompanyConsensus Rating ScoreConsensus RatingConsensus Price Target% Upside from Current Price
Nymox Pharmaceutical Co. stock logo
NYMX
Nymox Pharmaceutical
0.00
N/AN/AN/A
Oxford Immunotec Global PLC stock logo
OXFD
Oxford Immunotec Global
0.00
N/AN/AN/A
Riot Platforms, Inc. stock logo
RIOT
Riot Platforms
3.09
Buy$17.3542.58% Upside
Meridian Bioscience, Inc. stock logo
VIVO
Meridian Bioscience
0.00
N/AN/AN/A
Vermillion, Inc. stock logo
VRML
Vermillion
0.00
N/AN/AN/A

Current Analyst Ratings Breakdown

Latest NYMX, VIVO, VRML, OXFD, and RIOT Analyst Ratings

DateCompanyBrokerageActionRatingPrice TargetDetails
6/17/2025
Riot Platforms, Inc. stock logo
RIOT
Riot Platforms
Needham & Company LLC
Subscribe to MarketBeat All Access for the recommendation accuracy rating
Boost Price TargetBuy ➝ Buy$12.00 ➝ $15.00
6/13/2025
Riot Platforms, Inc. stock logo
RIOT
Riot Platforms
JPMorgan Chase & Co.
Subscribe to MarketBeat All Access for the recommendation accuracy rating
Boost Price TargetOverweight ➝ Overweight$13.00 ➝ $14.00
5/2/2025
Riot Platforms, Inc. stock logo
RIOT
Riot Platforms
Needham & Company LLC
Subscribe to MarketBeat All Access for the recommendation accuracy rating
Lower Price TargetBuy ➝ Buy$13.50 ➝ $12.00
4/28/2025
Riot Platforms, Inc. stock logo
RIOT
Riot Platforms
Piper Sandler
Subscribe to MarketBeat All Access for the recommendation accuracy rating
Lower Price TargetOverweight ➝ Overweight$23.00 ➝ $18.00
(Data available from 7/6/2022 forward. View 10+ years of historical ratings with our analyst ratings screener.)
CompanyAnnual RevenuePrice/SalesCashflowPrice/CashBook ValuePrice/Book
Nymox Pharmaceutical Co. stock logo
NYMX
Nymox Pharmaceutical
N/AN/AN/AN/A($0.01) per shareN/A
Oxford Immunotec Global PLC stock logo
OXFD
Oxford Immunotec Global
$73.71M7.75$0.02 per share1,408.78$8.08 per share2.72
Riot Platforms, Inc. stock logo
RIOT
Riot Platforms
$376.66M11.54$0.94 per share13.01$9.14 per share1.33
Meridian Bioscience, Inc. stock logo
VIVO
Meridian Bioscience
$333.02M4.49$1.78 per share19.13$8.41 per share4.04
Vermillion, Inc. stock logo
VRML
Vermillion
$4.54M3.68N/AN/A$0.09 per share1.91
CompanyNet IncomeEPSTrailing P/E RatioForward P/E RatioP/E GrowthNet MarginsReturn on Equity (ROE)Return on Assets (ROA)Next Earnings Date
Nymox Pharmaceutical Co. stock logo
NYMX
Nymox Pharmaceutical
-$6.58M-$0.04N/AN/AN/AN/A-1,589.50%-117.25%N/A
Oxford Immunotec Global PLC stock logo
OXFD
Oxford Immunotec Global
-$1.81M-$0.05N/AN/AN/A-30.51%-8.39%-7.63%N/A
Riot Platforms, Inc. stock logo
RIOT
Riot Platforms
$109.40M-$1.32N/AN/AN/A-86.93%-13.97%-11.99%7/30/2025 (Estimated)
Meridian Bioscience, Inc. stock logo
VIVO
Meridian Bioscience
$42.46M$0.9735.02N/A12.70%16.74%13.09%N/A
Vermillion, Inc. stock logo
VRML
Vermillion
-$15.24MN/AN/AN/A-307.31%-155.25%-103.47%N/A

Latest NYMX, VIVO, VRML, OXFD, and RIOT Earnings

DateQuarterCompanyConsensus EstimateReported EPSBeat/MissGap EPSRevenue EstimateActual RevenueDetails
7/30/2025Q2 2025
Riot Platforms, Inc. stock logo
RIOT
Riot Platforms
-$0.27N/AN/AN/A$146.66 millionN/A
5/1/2025Q1 2025
Riot Platforms, Inc. stock logo
RIOT
Riot Platforms
-$0.25-$0.90-$0.65-$0.90$159.60 million$161.39 million
CompanyAnnual PayoutDividend Yield3-Year Dividend GrowthPayout RatioYears of Consecutive Growth
Nymox Pharmaceutical Co. stock logo
NYMX
Nymox Pharmaceutical
N/AN/AN/AN/AN/A
Oxford Immunotec Global PLC stock logo
OXFD
Oxford Immunotec Global
N/AN/AN/AN/AN/A
Riot Platforms, Inc. stock logo
RIOT
Riot Platforms
N/AN/AN/AN/AN/A
Meridian Bioscience, Inc. stock logo
VIVO
Meridian Bioscience
N/AN/AN/AN/AN/A
Vermillion, Inc. stock logo
VRML
Vermillion
N/AN/AN/AN/AN/A
CompanyDebt-to-Equity RatioCurrent RatioQuick Ratio
Nymox Pharmaceutical Co. stock logo
NYMX
Nymox Pharmaceutical
N/A
0.19
0.19
Oxford Immunotec Global PLC stock logo
OXFD
Oxford Immunotec Global
N/A
15.96
14.85
Riot Platforms, Inc. stock logo
RIOT
Riot Platforms
0.20
3.23
3.23
Meridian Bioscience, Inc. stock logo
VIVO
Meridian Bioscience
0.07
3.63
2.46
Vermillion, Inc. stock logo
VRML
Vermillion
0.20
2.51
2.49

Institutional Ownership

CompanyInstitutional Ownership
Nymox Pharmaceutical Co. stock logo
NYMX
Nymox Pharmaceutical
1.14%
Oxford Immunotec Global PLC stock logo
OXFD
Oxford Immunotec Global
91.90%
Riot Platforms, Inc. stock logo
RIOT
Riot Platforms
40.27%
Meridian Bioscience, Inc. stock logo
VIVO
Meridian Bioscience
89.72%
Vermillion, Inc. stock logo
VRML
Vermillion
18.09%
CompanyEmployeesShares OutstandingFree FloatOptionable
Nymox Pharmaceutical Co. stock logo
NYMX
Nymox Pharmaceutical
390.51 million41.64 millionOptionable
Oxford Immunotec Global PLC stock logo
OXFD
Oxford Immunotec Global
27325.96 millionN/ANot Optionable
Riot Platforms, Inc. stock logo
RIOT
Riot Platforms
340357.26 million332.51 millionOptionable
Meridian Bioscience, Inc. stock logo
VIVO
Meridian Bioscience
70244.01 million43.00 millionOptionable
Vermillion, Inc. stock logo
VRML
Vermillion
4397.38 millionN/ANot Optionable

Recent News About These Companies

Vermillion, SD Hourly Weather Forecast
Vermillion named Tree City USA
Vermillion girls' basketball rallies to win Class A state title
2023 HW Vanguard: Dale Vermillion
Goodwill coming to Vermillion
Vermillion, SD 10-Day Weather Forecast
Camellia Vermillion
Dr. Richard L. Knutson
Vermillion Elementary School
Dr. Kenneth J. Vermillion
Vermillion, KS Weather Conditions

New MarketBeat Followers Over Time

Top Headlines

View All Headlines
Nymox Pharmaceutical stock logo

Nymox Pharmaceutical NASDAQ:NYMX

Nymox Pharmaceutical Corporation, a biopharmaceutical company, engages in the research and development of drugs for the aging population in Canada, the United States, Europe, and internationally. Its lead drug candidate is Fexapotide Triflutate (NX-1207), which is in various clinical trials for the treatment of benign prostatic hyperplasia and low grade localized prostate cancer, as well as is in preclinical studies for hepatocellular carcinoma. The company also develops and markets NicAlert for detecting tobacco product usage; and TobacAlert for detecting second-hand smoke exposure. In addition, it develops drugs for the treatment of Alzheimer's disease. Nymox Pharmaceutical Corporation was founded in 1989 and is headquartered in Nassau, the Bahamas.

Oxford Immunotec Global stock logo

Oxford Immunotec Global NASDAQ:OXFD

Oxford Immunotec Global PLC, a diagnostics company, focuses on developing and commercializing proprietary tests for immunology and infectious diseases in the United States, Europe, Asia, and internationally. The company develops its products using its T-SPOT technology platform that measures marker-specific cellular (T cells) responses at a single cell level and inform the diagnosis, prognosis, and monitoring of patients with immune-regulated conditions. It develops and markets T-SPOT.TB test used to test for tuberculosis; and reagents and methods to purify white blood cells for use in immunology assays. In addition, the company offers T-SPOT.CMV, an immune monitoring test for cytomegalovirus (CMV) for the quantification of effector T cells that respond to stimulation by antigens specific for CMV, as well as for the monitoring of CMV-seropositive responses in transplant recipients at various time-points post-transplantation applications. It serves independent laboratories, hospital systems, and public and private institutions. Oxford Immunotec Global PLC was founded in 2002 and is headquartered in Abingdon, the United Kingdom.

Riot Platforms stock logo

Riot Platforms NASDAQ:RIOT

$12.17 -0.03 (-0.25%)
Closing price 07/3/2025 03:59 PM Eastern
Extended Trading
$12.18 +0.01 (+0.10%)
As of 07/3/2025 04:59 PM Eastern
Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more.

Riot Platforms, Inc., together with its subsidiaries, operates as a bitcoin mining company in North America. The company operates through three segments: Bitcoin Mining, Data Center Hosting, and Engineering. It also provides co-location services for institutional-scale bitcoin mining companies; critical infrastructure and workforce for institutional-scale miners to deploy and operate their miners; operation of data centers; and maintenance/management of computing capacity. In addition, the company engages in the design and manufacturing of power distribution equipment and custom engineered electrical products; and electricity distribution product design, manufacture, and installation services primarily focused on large-scale commercial, and governmental customers, as well as a range of markets, including data center, power generation, utility, water, industrial, and alternative energy. The company was formerly known as Riot Blockchain, Inc. Riot Platforms, Inc. was incorporated in 1998 and is based in Castle Rock, Colorado.

Meridian Bioscience stock logo

Meridian Bioscience NASDAQ:VIVO

Meridian Bioscience, Inc. engages in the development, production, sale, and distribution of diagnostic products. Its platforms include molecular, immunoassay, urea breath, and blood chemistry. It operates through the Diagnostics and Life Science segments. The Diagnostics segment consists of manufacturing operations for infectious disease and blood chemistry products and the sale and distribution of diagnostics products domestically and abroad. The Life Science segment distributes bulk antigens, antibodies, polymerase chain reaction/ quantitative PCR reagents, nucleotides, competent cells, and bioresearch reagents used by researchers, agri-bio companies, and other diagnostic manufacturing companies. The company was founded by William J. Motto in 1976 and is headquartered in Cincinnati, OH.

Vermillion stock logo

Vermillion NASDAQ:VRML

Vermillion, Inc., together with its subsidiaries, discovers, develops, and commercializes diagnostic and bio-analytical solutions that help physicians to diagnose, treat, and enhance gynecologic health outcomes for women primarily in the United States. The company's diagnostic tests include OVA1, a blood test for the pre-surgical identification of women who are at high risk of having a malignant ovarian tumor; and Overa, a multivariate index assay second generation test to determine the malignancy of ovarian cancer in women. It also offers in-vitro diagnostic (IVD) trial services to third-party customers; and laboratory services to meet the needs of IVD manufacturers to commercialize high-complexity assays. The company serves clinical reference laboratories, hospital laboratories, and physician offices. Vermillion, Inc. was founded in 1993 and is headquartered in Austin, Texas.